Drug intelligence / Profile preview

Bismuth cation

Development stage
Unknown
Modality
DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Bismuth cation (Bi3+) is the trivalent, positively charged ion of the element bismuth. It serves as the active moiety in several medicinal compounds, most notably in gastrointestinal agents such as bismuth subsalicylate and other bismuth salts. Bismuth cations exhibit antimicrobial and bactericidal properties by interfering with bacterial adhesion to mucosal surfaces and disrupting microbial cell walls. They also have anti-inflammatory effects when present as part of salicylate-containing compounds. Bismuth-based drugs are primarily used for symptomatic relief of gastrointestinal disorders including diarrhea, heartburn, indigestion, and upset stomach. Additionally, certain formulations are used in combination therapies for *Helicobacter pylori* eradication in peptic ulcer disease[1][4][5][8]. The precise mechanism of action is not fully understood but involves both direct antimicrobial activity and modulation of intestinal secretions[4][5].

Other names
Bi3+bismuth(3+)trivalent bismuthBi+3
02

Targets

MUC5AC (Mucin-5AC)Bacterial cell wall synthesis enzymesChitin

Beyond the preview

Go deeper on Bismuth cation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bismuth cation.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call